- Open
- 48.50
- High
- 49.00
- Low
- 48.99
- Close
- 49.00
- Change
- -0.50 (-1.03%)
- Volume
- 2,533
⌘K
| 16 Sept 2024 | 14:31:43 | PDS: Updated Results, VERSATILE-002 Phase 2 Trial |
| 13 Aug 2024 | 15:57:46 | PDS Biotech: Business Update and Q2 2024 Results |
| 2 Aug 2024 | 12:21:26 | Replacement RNS: PDS Biotech Aligns with FDA |
| 2 Aug 2024 | 07:00:05 | PDS Biotech Aligns with FDA on Phase 3 Trial |
| 30 Jul 2024 | 07:00:10 | Q-Bot Fundraising |
| 12 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 27 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 8 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
NetScientific is a dynamic investment firm that focuses on identifying and supporting promising companies in the fields of life sciences, healthcare, sustainability, and technology. The company works to develop and commercialize these ventures, with the ultimate goal of generating value for its shareholders.
| 16 Sept 2024 | 14:31:43 | PDS: Updated Results, VERSATILE-002 Phase 2 Trial |
| 13 Aug 2024 | 15:57:46 | PDS Biotech: Business Update and Q2 2024 Results |
| 2 Aug 2024 | 12:21:26 | Replacement RNS: PDS Biotech Aligns with FDA |
| 2 Aug 2024 | 07:00:05 | PDS Biotech Aligns with FDA on Phase 3 Trial |
| 30 Jul 2024 | 07:00:10 | Q-Bot Fundraising |
| 12 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 27 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 8 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
NetScientific is a dynamic investment firm that focuses on identifying and supporting promising companies in the fields of life sciences, healthcare, sustainability, and technology. The company works to develop and commercialize these ventures, with the ultimate goal of generating value for its shareholders.